Evidence map›Paper›PMID 30631433›Full record

ReviewF1000Research2018

Recent advances in managing benign prostatic hyperplasia: The Rezūm System.

Dominique Guelce, Dominique Thomas, Dean Elterman, Bilal Chughtai

Registry-linked trialOpen access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05851521 (HERMES Study), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05851521 naunknown statusnot on this mapstarted 2023, after this paper: background citation

HERMES Study: A Randomized Clinical Trial To Evaluate Lower Urinary Tract Symptoms Differences Between Indwelling Catheter And Temporary Prostatic Stent In Patients Undergoing Minimally Invasive Procedures For The Treatment Of Localized Prostate Cancer Or Benign Prostatic Hyperplasia

TypeinterventionalSponsorLyx InstituteRan2023 to 2025Enrolled120ConditionsLower Urinary Tract Symptoms, Prostatic Hyperplasia, Prostatic Cancer, Urinary RetentionArmsTemporary prostatic stent (Exime®), Indwelling catheter
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Dominique GuelceUrology, Weill Cornell Medical Center, New York, NY, 10065, USA.
Dominique ThomasUrology, Weill Cornell Medical Center, New York, NY, 10065, USA.ORCID 0000-0002-0748-1746
Dean EltermanUrology, University of Toronto, Toronto, Ontario, M5T2S8, Canada.
Bilal ChughtaiUrology, Weill Cornell Medical Center, New York, NY, 10065, USA.
Cornell University · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benign Prostatic Hyperplasia is a common condition that affects 50% of men in their 50

Indexed as

SteamAnimalsClinical Trials as TopicDisease ManagementHumansLower Urinary Tract SymptomsMaleProstatic HyperplasiaQuality of LifeTreatment OutcomeSteamLower Urinary Tract SymptomsRezum; Benign Prostatic Hyperplasia

Identifiers

PMID30631433
PMCPMC6290970
OpenAlexW2905379739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.